| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.35 | 7e-11 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-11 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-10 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-09 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.22 | 5e-07 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-07 |